Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research

Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncology. Although it is considered a standard for resected stage II-IIIA patients according to the available guidelines, many questions are still open. Among them, it should be acknowledged that the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonomi, Maria, Pilotto, Sara, Milella, Michele, Massari, Francesco, Cingarlini, Sara, Brunelli, Matteo, Chilosi, Marco, Tortora, Giampaolo, Bria, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284429/
https://www.ncbi.nlm.nih.gov/pubmed/22206620
http://dx.doi.org/10.1186/1756-9966-30-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284429/
https://www.ncbi.nlm.nih.gov/pubmed/22206620
http://dx.doi.org/10.1186/1756-9966-30-115

Ejemplares similares